235 related articles for article (PubMed ID: 27806724)
1. A network-pathway based module identification for predicting the prognosis of ovarian cancer patients.
Wang X; Wang SS; Zhou L; Yu L; Zhang LM
J Ovarian Res; 2016 Nov; 9(1):73. PubMed ID: 27806724
[TBL] [Abstract][Full Text] [Related]
2. Four genes relevant to pathological grade and prognosis in ovarian cancer.
Pan X; Chen Y; Gao S
Cancer Biomark; 2020; 29(2):169-178. PubMed ID: 32444534
[TBL] [Abstract][Full Text] [Related]
3. Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis.
Xu Z; Zhou Y; Cao Y; Dinh TL; Wan J; Zhao M
Med Oncol; 2016 Nov; 33(11):130. PubMed ID: 27757782
[TBL] [Abstract][Full Text] [Related]
4. Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients.
Li X; Tian R; Gao H; Yang Y; Williams BRG; Gantier MP; McMillan NAJ; Xu D; Hu Y; Gao Y
Sci Rep; 2017 Nov; 7(1):16495. PubMed ID: 29184082
[TBL] [Abstract][Full Text] [Related]
5. Gene co-expression network reveals shared modules predictive of stage and grade in serous ovarian cancers.
Sun Q; Zhao H; Zhang C; Hu T; Wu J; Lin X; Luo D; Wang C; Meng L; Xi L; Li K; Hu J; Ma D; Zhu T
Oncotarget; 2017 Jun; 8(26):42983-42996. PubMed ID: 28562334
[TBL] [Abstract][Full Text] [Related]
6. Application of a co‑expression network for the analysis of aggressive and non‑aggressive breast cancer cell lines to predict the clinical outcome of patients.
Guo L; Zhang K; Bing Z
Mol Med Rep; 2017 Dec; 16(6):7967-7978. PubMed ID: 28944917
[TBL] [Abstract][Full Text] [Related]
7. Platform-Independent Classification System to Predict Molecular Subtypes of High-Grade Serous Ovarian Carcinoma.
Shilpi A; Kandpal M; Ji Y; Seagle BL; Shahabi S; Davuluri RV
JCO Clin Cancer Inform; 2019 Apr; 3():1-9. PubMed ID: 31002564
[TBL] [Abstract][Full Text] [Related]
8. Systematic module approach identifies altered genes and pathways in four types of ovarian cancer.
Liu J; Wang HL; Ma FM; Guo HP; Fang NN; Wang SS; Li XH
Mol Med Rep; 2017 Dec; 16(6):7907-7914. PubMed ID: 28983627
[TBL] [Abstract][Full Text] [Related]
9. AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer.
Svoboda M; Meshcheryakova A; Heinze G; Jaritz M; Pils D; Castillo-Tong DC; Hager G; Thalhammer T; Jensen-Jarolim E; Birner P; Braicu I; Sehouli J; Lambrechts S; Vergote I; Mahner S; Zimmermann P; Zeillinger R; Mechtcheriakova D
BMC Genomics; 2016 Aug; 17(1):643. PubMed ID: 27527602
[TBL] [Abstract][Full Text] [Related]
10. Comparisons of gene coexpression network modules in breast cancer and ovarian cancer.
Zhang S
BMC Syst Biol; 2018 Apr; 12(Suppl 1):8. PubMed ID: 29671401
[TBL] [Abstract][Full Text] [Related]
11. The Prognostic 97 Chemoresponse Gene Signature in Ovarian Cancer.
Matondo A; Jo YH; Shahid M; Choi TG; Nguyen MN; Nguyen NNY; Akter S; Kang I; Ha J; Maeng CH; Kim SY; Lee JS; Kim J; Kim SS
Sci Rep; 2017 Aug; 7(1):9689. PubMed ID: 28851888
[TBL] [Abstract][Full Text] [Related]
12. Systematic prediction of key genes for ovarian cancer by co-expression network analysis.
Wang M; Wang J; Liu J; Zhu L; Ma H; Zou J; Wu W; Wang K
J Cell Mol Med; 2020 Jun; 24(11):6298-6307. PubMed ID: 32319226
[TBL] [Abstract][Full Text] [Related]
13. Identifying prognostic signature in ovarian cancer using DirGenerank.
Wang JY; Chen LL; Zhou XH
Oncotarget; 2017 Jul; 8(28):46398-46413. PubMed ID: 28615526
[TBL] [Abstract][Full Text] [Related]
14. ICan: an integrated co-alteration network to identify ovarian cancer-related genes.
Zhou Y; Liu Y; Li K; Zhang R; Qiu F; Zhao N; Xu Y
PLoS One; 2015; 10(3):e0116095. PubMed ID: 25803614
[TBL] [Abstract][Full Text] [Related]
15. High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway.
Yoshihara K; Tsunoda T; Shigemizu D; Fujiwara H; Hatae M; Fujiwara H; Masuzaki H; Katabuchi H; Kawakami Y; Okamoto A; Nogawa T; Matsumura N; Udagawa Y; Saito T; Itamochi H; Takano M; Miyagi E; Sudo T; Ushijima K; Iwase H; Seki H; Terao Y; Enomoto T; Mikami M; Akazawa K; Tsuda H; Moriya T; Tajima A; Inoue I; Tanaka K;
Clin Cancer Res; 2012 Mar; 18(5):1374-85. PubMed ID: 22241791
[TBL] [Abstract][Full Text] [Related]
16. Weighted gene co-expression network analysis of gene modules for the prognosis of esophageal cancer.
Zhang C; Sun Q
J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):319-325. PubMed ID: 28585144
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of an immune gene-set based Prognostic signature in ovarian cancer.
Shen S; Wang G; Zhang R; Zhao Y; Yu H; Wei Y; Chen F
EBioMedicine; 2019 Feb; 40():318-326. PubMed ID: 30594555
[TBL] [Abstract][Full Text] [Related]
18. Network-based survival-associated module biomarker and its crosstalk with cell death genes in ovarian cancer.
Jin N; Wu H; Miao Z; Huang Y; Hu Y; Bi X; Wu D; Qian K; Wang L; Wang C; Wang H; Li K; Li X; Wang D
Sci Rep; 2015 Jun; 5():11566. PubMed ID: 26099452
[TBL] [Abstract][Full Text] [Related]
19. Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian Cancer by Bioinformatics Analysis.
Zhang J; Huang S; Quan L; Meng Q; Wang H; Wang J; Chen J
Biomed Res Int; 2021; 2021():8883800. PubMed ID: 33829065
[TBL] [Abstract][Full Text] [Related]
20. Predicting Functional Modules of Liver Cancer Based on Differential Network Analysis.
Hu B; Chang X; Liu X
Interdiscip Sci; 2019 Dec; 11(4):636-644. PubMed ID: 30603844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]